Literature DB >> 1844775

[Porphyria induced by valproic acid: clinical case].

P Jalil1, F Vergara.   

Abstract

A 47 year-old woman with juvenile myoclonic epilepsy received anticonvulsant therapy with valproate, 200 mg 4 times a day. Severe abdominal pain and vomiting developed 3 days after initiation of therapy, and she became comatose requiring artificial ventilation. Increased urinary output of delta-amino-levulinic acid (48 uM/24 hr, 8 times normal) and porphobilinogen (9 uM/24 hr, twice normal) were demonstrated. Complete recovery took place 5 days after discontinuation of valproate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1844775

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  1 in total

1.  Levetiracetam in idiopathic generalised epilepsy and porphyria cutanea tarda.

Authors:  Leonilda Bilo; Roberta Meo; Maria Fulvia de Leva
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.